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1. Introduction 
Osteoporosis is characterized by low bone mass and destruction of the micro architecture of 
bone tissue, resulting in increased bone fragility and susceptibility to fractures (NIH 2001). 
The clinical usefulness of T-score at disabled people on the recognition of people with low 
BMD remains unclear according to ranking system of the World Health Organization (WHO 
1994). Despite the increased number of risk factors in people with disabilities no guidelines 
are available on BMD measurements; so it would be more appropriate to use the term low 
bone mass instead of osteoporosis or osteopenia and also take into account the Z-score 
obtained from the measurement of bone densitometry which is the number of standard 
deviations above or below that normally expected for someone of similar age, sex, weight 
and race in question (Dionyssiotis, 2011c, 2011d). 
In disabled subjects there are differences according to the type of injury (i.e. lesion with a 
level of injury vs. upper motor neuron pyramidal lesion), the type of lesion; complete (an 
absence of sensory or motor function below the neurological level, including the lowest 
sacral segment) vs. incomplete lesion (partial preservation of motor and/or sensory function 
below the neurological level, including the lowest sacral segment), the progression or not of 
the disease (i.e. progressive multiple sclerosis vs. complete paraplegia), life expectancy, the 
residual mobility and functionality, the ability to walk and stand (i.e. incomplete paraplegia 
vs. quadriplegia vs. high-low paraplegia), drug treatment (i.e. frequent corticosteroid 
therapy in multiple sclerosis vs. long-term therapy with anticoagulants in paraplegia), the 
degree of spasticity (i.e. flaccid vs. spastic paralysis) and it is necessary to take into account 
the issue of fatigue and muscle weakness. Depression in these subjects is usual; complicates 
the proposed treatments and limits mobility. Complete and incomplete disabled differ also 
in physical abilities. Moreover, subjects with complete injuries have greater bone loss than 
those with an incomplete injury (Garland et al., 1994) and as has already been shown in 
Brown-Sequard subjects (incomplete spinal cord lesion) where BMD of the more paretic 
knee was lower than that of the stronger knee (Lazo et al., 2001). 
However, there are also similarities; for example the clinical equivalence of diseases with 
different physiopathology, location, evolution, etc. A severe form of multiple sclerosis (MS) 
can result in a wheelchair bound patient having a clinical figure equivalent to spinal cord 
injury paraplegia. One patient with MS may have better walking gait pattern in comparison 
with a patient with incomplete paraplegia but may also be unable to walk, bedridden and 
vice versa (Dionyssiotis, 2011c, 2011d).  
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In addition the role of factors which do not change, i.e.: race or gender is inadequately 
clarified. Studies in disabled women debate that bones are more affected compared to 
disabled men. In chronic spinal cord injured women a tendency to have lower bone mass 
than men (Coupaud et al., 2009) and higher rates of lower bone mass with lower T-scores 
compared to women with other disabilities have been reported (Smeltzer et al., 2005).  
2. Spinal cord injury 
Bone loss in spinal cord injury (SCI) is a multifactorial disease in acute and chronic phase 
and can be enhanced by the lack of weight bearing, muscular tension on bone or other 
neural factors associated with the injury. Moreover, differentiation of the sympathetic 
nervous system after SCI is leading to venous and capillary vascular stasis. Some additional 
non-mechanical factors to stimulate bone loss include poor nutritional adequacy, gonadal 
changes and other endocrine disorders (Chantraine 1978; Chantraine et al., 1979b; Jiang et 
al., 2007; Maimoun et al., 2006).  
2.1 Bone mineral density 
In individuals with SCI bone loss begins immediately after injury (Bauman et al., 1997; 
Uebelhart et al., 1995). SCI related bone impairment below the level of injury is much greater 
compared with other conditions (i.e. age, immobilization, bed rest, lack of gravity 
environment). A reduction of bone mineral content (BMC) during the first years after the 
injury of 4% per month in regions rich in cancellous bone, and 2% per month on sites 
containing mainly cortical bone is reported (Wilmet et al., 1995). According to another study 
25 out of 41 patients with SCI (61%) met WHO’s criteria for osteoporosis, eight (19.5%) were 
osteopenic and only eight (19.5%) showed normal values (Lazo et al., 2001). In SCI children 
(boys and girls) values for bone mineral density (BMD) at the hip were approximately 60% 
of normal, or had a Z-score that indicated a 1.6-1.8 SD reduction in BMD compared with 
age- and sex-matched peers (Lauer et al., 2007). 
In studies with peripheral quantitative computed tomography (p QCT) in spinal cord 
injured subjects bone loss in the epiphyses was 50% in the femur and 60% in the tibia, while 
in the diaphyses of these bones was 35% and 25%, respectively, meaning that bone loss in 
the epiphyses almost doubled the loss in the diaphyses (Eser et al., 2004). This study also 
showed that bone loss between trabecular and cortical bone compartment differs in 
mechanism, i.e. in the epiphyses bone is lost due to the decrease in trabecular, while in 
diaphysis, the cortical bone density is maintained and bone is lost due to endocortical 
resorption. In line with the previous study another p QCT study, performed in complete 
paraplegics with high (thoracic 4-7) and low (thoracic 8-12) neurological level of injury at the 
tibia, found a loss of trabecular (57.5% vs. 51%, in high vs. low paraplegics, respectively) and 
cortical bone (3.6% and 6.5%, respectively), suggesting that trabecular bone is more affected 
during the years of paralysis in comparison with cortical bone (Dionyssiotis et al., 2007). In 
the same study both paraplegic groups had a similar loss of total BMD (46.90% vs. 45.15%, 
in high vs. low paraplegics, respectively) suggesting that a homogenously deficit pattern 
occurs in the epiphyseal area, especially in the group of low paraplegics because the central 
and the peripheral of the cross sectional area of bone were similarly affected. On the 
contrary, in high paraplegics’ group trabecular bone loss was higher suggesting an 
increasing endocortical remodeling keeping the total BMD similar. Concerning cortical 
geometric properties the results had shown an increased endosteal circumference between 
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both paraplegic groups vs. controls leading to reduction of cortical thickness, 19.78% vs. 
16.98% in paraplegic groups respectively, whereas periosteal circumference was comparable 
to controls (Fig. 1).  
 
 
   
Fig. 1. Peripheral quantitative computed tomography (p QCT) tibia slices in control (a) and 
paraplegic subject (b), (scanner XCT 3000 Stratec, Medizintechnik, Pforzheim, Germany). 
Areas in red represent trabecular bone, while areas in grey represent fat; pQCT allows the 
measurements of true volumetric densities at a minimum exposure to X-rays, assess cortical 
and trabecular bone density separately as well as to evaluate the geometrical properties of 
long bones non-invasively, adapted from Dionyssiotis, 2011c, 2011d, with permission. 
Regarding tetraplegic patients statistically significant differences were found in BMD of the 
spine, trochanteric region and upper limbs between paraplegic and tetraplegic patients but not 
in the femoral neck, pelvis, and lower extremities (Tzuzuku et al., 1999). Indeed, the effects on 
spinal BMD differed from previously published work in which the investigation was mainly 
focused in paraplegics (Biering-Sorensen et al., 1988, 1991; Leslie & Nance, 1993).  
The importance of mechanical loading and site specificity to maintain or increase BMD is 
already shown (Lanyon, 1986).  According to bone loss there are some interesting features in 
spinal cord injured subjects; demineralization is area dependent, occurs exclusively in the 
areas below the level of injury (Dauty et al., 2000), affecting mainly paralyzed extremities 
and increasing from proximal to distal regions i.e. in paraplegics weight bearing skeleton 
regions, as the distal end of femur and proximal tibia, which are rich in cancellous bone, 
while region of the diaphysis of the femur and tibia, rich in cortical bone is reserved (Eser et 
al., 2004; Kiratli et al., 2000; Dionyssiotis et al., 2007). Moreover, bone loss between 
trabecular and cortical bone compartment differs in mechanism, i.e. in the epiphyses is due 
to decrease in trabecular but in diaphysis cortical bone is maintained and bone is lost 
through endocortical resorption by reducing cortical wall thickness (Dionyssiotis et al., 2007; 
Eser et al., 2004). 
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Women with disabilities have a higher risk of losing bone mass compared to men because of 
the inevitable reduction in estrogen levels that occurs at menopause. Findings that women 
with serious disabilities have low bone density are not surprising and are probably related 
to the lack of activity (reduced mobility, reduced loading on bone) and worsening of the 
disability. Regarding women with complete SCI, the initial bone loss in the lumbar spine is 
negligible. Post injury over a period of years BMD in SCI women is maintained or increases 
compared with non-injured age-matched women, in whom BMD decreases during aging 
(Dionyssiotis, 2011c). 
2.2 Duration of paralysis and bone steady state  
The duration of paralysis affects the degree of bone loss in regions below the level of injury. 
A study of 21 men with SCI with an average duration of 10.6 years, using dual-energy X-ray 
absorptiometry (DXA), expressed at various levels of injury an inverse relationship between 
BMD in the legs and the duration of the lesion (Clasey et al., 2004), while others found a 
weaker relationship regarding the microarchitecture of the distal end of tibia (Modlesky et 
al., 2004).  
In a study which included paraplegics with duration of paralysis of 14 ± 11.5 years a 
positive correlation between the duration of paralysis and the degree of bone loss was found 
(Eser et al., 2004). The length of immobilization in the acute posttraumatic period increased 
bone loss in the legs, particularly in the proximal tibia; over 50% of bone mass was lost (in 
the affected areas) in the period of ten years after the injury (Dauty et al., 2000). When 
subjects categorized depending on the length of the lesion (0-1, 1-5, 6-9, 10-19, 20-29, 30-39, 
40-49, and 50-59 years after the injury), in all age groups bone loss to the hip area occurs a 
year after the injury (Szollar et al., 1998). 
Using DXA and QUS (quantitative ultrasound) measurements in 100 men with SCI, aged 18 
to 60 years, it was found that bone density decreases over time in all measured points, while 
bone loss followed a linear pattern in the femoral neck and distal epiphysis, stabilized 
within three years after the injury. On the contrary, Z-scores of the distal region of the 
diaphysis of the tibia continued to decrease even beyond ten years after the injury (Zehnder 
et al, 2004). Duration of paralysis related bone loss in the legs of monozygotic twins with 
chronic paraplegia in comparison with their able-bodied co-twins has been also reported 
(Bauman et al., 1999).  
The results of a comparison of chronic complete paraplegic men vs. controls in another 
study found a reduction of BMD in paraplegics’ legs independent of the neurological level 
of lesion. BMD of the legs was negatively correlated with the duration of paralysis in the 
total paraplegic group, but after investigation according to the neurological level this 
correlation was due to the strong correlation of high paraplegics’ legs BMD with the 
duration of paralysis, suggesting a possible influence of the neurological level of injury on 
the extent of bone loss (Dionyssiotis et al., 2008). A significant inverse relationship between 
percentage-matched in BMD leg, arm and trunk values and time since injury was found 
when varying levels of SCI were analyzed (Clasey et al., 2004).  
Studies are supporting the concept of a new bone steady state at 16-24 months after injury, 
especially for bone metabolic process (Bauman WA 1997; Demirel et al., 1998; Szollar et al., 
1998), but BMD decreases over the years at different areas and is inversely related to the 
time of the injury, which means continuous bone loss beyond the first two years after the 
injury (Coupaud et al., 2009; Dionyssiotis et al., 2008; Eser et al., 2004) (Fig. 2). 
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Fig. 2. The duration of paralysis was inversely related with trabecular bone loss in spinal cord 
injured subjects. Exponential correlation between volumetric trabecular bone mineral density 
BMD trab and duration of paralysis in high paraplegics was found to fit best. On the contrary 
no significant decrease in BMD cort of the diaphyses was found in total paraplegic group. 
BMD parameters were measured by pQCT in 31 paraplegic men in chronic stage (>1.5 years of 
injury). Spinal cord injury paraplegic men were allocated into 2 subgroups based on the 
neurological level of injury; subgroup A (n=16, Thoracic (T)4-T7 neurological level of injury) 
and subgroup B (n=15, T8-T12 neurological level of injury). BMDtrab: BMD trabecular; 
BMDcort: BMD cortical; (adapted from Dionyssiotis et al., 2011a, with permission). 
The role played by factors such as race or gender of patients is not yet clear documented, but 
studies indicated more loss in women than men (Garland et al., 2001). Loss of bone is 
closing fracture threshold from 1 to 5 years after injury (Szollar et al., 1998) and risk factors 
for fractures after spinal cord injury are gender (women are more at risk than men), age and 
duration of injury (increasing age and duration of injury increases the risk of fracture with a 
statistically significant increase in 10 years after injury), the type of injury (complete SCI 
subjects have more fractures than incomplete), low body mass index (BMI) and low bone 
density in the tibia (Garland et al., 2004a,b; Garland et al., 1992; Lazo et al., 2001).  
2.3. The role of central nervous system  
2.3.1 Sympathetic denervation in SCI 
Spinal cord injury is a dynamic process that is related to alterations in both the central and 
peripheral sympathetic nervous system (SNS). Sympathetic denervation in SCI may cause 
arteriovenous shunts and a slowdown of intraosseous blood flow, thus increasing bone 
resorption (Chantraine et al., 1979). With high-level spinal cord lesions the SNS is 
disproportionately involved when compared with the parasympathetic nervous system. In a 
complete high-level SCI, functioning in the isolated spinal cord below the lesion becomes 
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independent of supraspinal control and has been termed ˝decentralization˝ of the SNS 
(Karlsson et al., 1998). 
Loss of supraspinal control leads to dysregulation of those homeostatic mechanisms 
normally influenced by the SNS through loss of facilitation or lack of inhibition (Teasell et 
al., 2000). Today there is clinical evidence that the sympathetic regulation of bone does exist 
in humans and plays a clinically important role in diseases characterized by excessive 
sympathetic activity (Schwartzman, 2000). The scientific finding about  sympathetic 
innervations of bone tissue (Takeda et al., 2002; Kondo et al., 2005) and its role in the 
regulation of bone remodelling is of major interest in situations where uncoupling between 
osteoclasts and osteoblasts occurs (Levasseur et al., 2003). 
2.3.2 Spasticity 
Controversial results have also been reported regarding the effect of spasticity on BMD in 
SCI paraplegics. A cross-sectional study of 41 SCI paraplegics reported less reduction of 
BMD in the spastic paraplegics SCI patients compared to the flaccid paraplegic SCI patients 
(Demirel et al., 1998). Others reported that spasticity may be protective against bone loss in 
SCI patients, however, without any preserving effect in the tibia (Dionyssiotis et al., 2011; 
Eser et al., 2005). A possible explanation for that could lie in the fact that in the present study 
all paraplegics were above thoracic (T)12 level with various degrees of spasticity according 
to the Ashworth scale. In addition, muscle spasms affecting the lower leg would mainly be 
extension spasms resulting in plantar flexion thus creating little resistance to the contracting 
muscles. Furthermore, the measuring sites of the tibia did not include any muscle insertions 
of either the knee or the ankle extensor muscles (Dionyssiotis et al., 2011a; Dionyssiotis, 
2011c). Other investigators also have not been able to establish a correlation between BMD 
and muscle spasticity (Lofvenmark et al., 2009). 
3. Multiple sclerosis 
Reduced mobility has been implicated as an important factor in bone loss in patients 
suffering from multiple sclerosis (MS) and it seems to greatly influence the BMD of the 
femur. However, the high proportion of ambulatory patients with bone loss suggest 
additional non-mechanical factors (Cosman et al., 1998; Dionyssiotis, 2011b). 
There is a high incidence of vitamin D deficiency in MS patients and is determined by levels 
of 25-hydroxy vitamin D <20ng/ml (Nieves et al., 1994). The reasons might be due to a 
combination of low dietary vitamin D intake and avoiding of sun exposure, and that 
because of MS symptoms may worsen after sun exposure (fatigue-related heat) leading 
these patients to avoid sun. Low testosterone alone in these populations does not explain 
bone loss and no clear effect of smoking or alcohol abuse to decreased bone mass could be 
established (Weinstock-Guttman et al., 2004).  
Glucocorticoid (GC)-induced osteoporosis (OP-GC) is the main type of secondary 
osteoporosis (Canalis et al., 2004; Canalis et al., 2007; Lakatos et al., 2000; Mazziotti et al., 
2006; Schwid et al., 1996; Shuhaibar et al., 2009). The mechanism is that excess GC causes a 
rapid and significant damage to bone quality. Now days we know that GCs act direct on 
bone mainly to the stromalosteoblastic lineage and at high concentrations alter 
differentiation, survival, and function of them causing a shift from osteoblastic to adipocytic 
differentiation of precursors; inducing apoptosis of mature osteoblasts; and inhibition of 
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synthesis and secretion of bone components (Manolagas, 2000; Pereira et al., 2002). Finally, 
GCs promote ostoclasts and stimulate bone resorption (Weinstein et al., 2002). The 
mechanisms of GCs action in bone has been studied extensively. In patients receiving 
chronic per os GC, bone loss is admitted rapidly and is evident within 6 or even 3 months 
(Cosman et al., 1998). A study investigated the effect of intravenously (i.v.) administration of 
glucocorticoids in MS patients found no clear effect on bone loss: on the contrary they 
reported an increase in BMD of the lumbar spine (Schwid et al., 1996). Prolonged treatment 
with glucocorticoids results in increased risk of fractures, evident at 3 months, regardless of 
changes in BMD. High dose, short-term i.v. treatment with GCs leads directly to reduction 
of bone formation and increased bone resorption, as indicated by markers of bone turnover 
(De Vries et al. 2007; Van Staa et al., 2000). Osteopenia not osteoporosis was significantly 
more frequent in patients with MS compared with controls, especially in women who 
received high dose methylprednisolone pulses (HDMP) in relapses period making 
important the regularly monitoring of BMD in these patients. The authors concluded that 
disability and the subsequent immobilization osteoporosis is the more serious factor in this 
group and treatment with repeated HDMP pulses did not cause osteoporosis in MS subjects 
followed-up for almost 8 years unlike chronic corticosteroid therapy which induces 
osteoporosis and/or recovery of BMD is permitted without permanent skeletal damage 
(Zorzon et al.,  2005). The lack of physical activity exacerbates osteoporosis. All MS patients 
should be considered high risk for osteoporosis. Prevention with calcium rich foods and 
dietary supplements containing vitamin D and antiosteoporotic drugs is necessary for these 
patients. Particular attention should be paid to transfers and falls prevention in this 
population to prevent fractures which occur easily and heal slowly (Cattaneo et al., 2007; 
Dionyssiotis, 2011b). 
In osteoporosis molecular mechanisms leading to bone loss are inadequately explained. 
There is evidence of interaction between bone and immune system. T cells’ activity could 
stimulate bone loss under certain circumstances such as estrogen deficiency. Women with 
post-menopausal osteoporosis have higher T cell activity than healthy post-menopausal 
subjects which could be also the case in inflammatory or autoimmune disorders like MS: 
receptor activator of nuclear factor kappa B ligand (RANKL) stimulates osteoclastogenesis 
and the same do cytokines, such as TNF-α, IL-1, or IL-11, all produced by T-cells activation, 
leading to bone destruction. On the contrary osteoprotegerin (OPG) is an osteoclastogenesis 
inhibitory factor preventing the function from RANKL. A balanced system of RANKL/OPG 
regulates bone metabolism. In MS this system is disturbed in favour of RANKL (Zhao et al., 
2008; Kurban et al., 2009).  
4. Stroke  
Disuse has been suggested as the main cause for loss of bone mass in patients immobilized 
because of stroke (Takamoto et al., 1995).  However, this was not confirmed in a prospective 
study, in which only weak associations between bone loss and motor function, activities of 
daily living (ADL), or ambulation were found (Ramnemark et al., 1999a). This could be 
explained by the selected severely affected patients, but it does raise questions about other 
risk factors for the development of hemiosteoporosis apart from paresis and immobilization 
(Ramnemark et al., 1999b).  
The critical role in pathogenesis of osteoporosis is attributed to hormonal processes and 
osteoporosis itself is often defined as generalized skeletal disorder. Findings of tibial bone 
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changes in hemiplegic patients are not compatible with this view. The adaptations are found 
in trabecular bone in the epiphysis as well as in cortical bone in the diaphysis. They 
represent an individually different distribution of local changes which can be explained by 
the feedback principles of the muscle-bone-unit, in which bone strength is controlled by the 
muscle forces that act upon the bone. Muscle forces acting habitually on the paretic limb are 
considerably less than on the opposite side. This reduction of forces reduces the strain on 
bones. This leads to loss of bone mass and bone strength (Runge et al., 2004).  
Determinants of bone mineral loss have been identified as duration of hemiplegia-induced 
immobilization and severity of palsy (Sato, 1996). A rapid and pronounced loss of BMD in 
the paretic extremities that progressed during the first year after stroke (Ramnemark et al., 
1999a) more pronounced during the first few months after stroke onset (Hamdy et al., 1993). 
The lower extremities lost BMD bilaterally, but the losses were significant after 12 months in 
the affected femur, proximal femur and trochanter. In immobile patients, this could explain 
the loss of BMD in the nonaffected leg as compared with the nonaffected arm, which even 
increased in BMD, probably due to increased compensatory activity (Ramnemark et al., 
1999a).  
Hemiosteoporosis has previously been described as being caused by disuse and vitamin D 
deficiency (Sato et al, 1996), and in a randomized study a significant decrease in the rate of 
bone loss in stroke patients with a mean duration of 4.8 years after stroke when 
supplemental vitamin D was given (Sato et al., 1997). Bone mineral loss was more 
pronounced in the upper than in lower limbs, and the difference between sides was more 
marked in long-standing poststroke hemiparesis. The upper versus lower difference may 
reflect that hemiparesis from stroke is commonly more severe in the upper limb. Notably, 
BMD on the nonhemiplegic side is intermediate between that for the hemiplegic side and 
that in control subjects. The decrease in mobility of the intact limb, resulting from stroke-
related need for assistance with activities of daily living, presumably results in mild 
osteoporosis paralleling the patient’s overall degree of immobilization (Sato et al., 1998, 
2000). 
5. Myelomeningocele and cerebral palsy 
Previous studies suggest that the level of neurological injury and mobility affect BMD in 
myelomeningocele (MMC). Studies concluded that loading of the lower limbs rather than  
child’s potential ability to walk because of the level of neurological lesion or residual motor 
capacity of lower limbs is a prognostic criterion for the BMD (Apkon et al., 2009; Ausili et 
al., 2008; Quan et al., 1998). This theory is probably challenged by other studies that revealed 
low values of forearm BMD in individuals and indicate that in this patient osteoporosis can 
be caused by neurogenic and metabolic mechanisms. The fact is that these patients are 
loading the arms through the use of crutches and wheelchairs and BMD values in the upper 
extremities are expected to be higher in relation to immobilized people (Quan et al., 1998). 
Subjects with MMC may have hypercalciuria associated with immobilization and an 
additional risk factor for osteoporosis in these patients group (Quan et al., 2003). Others 
support that low-energetic fractures in MMC children may result from metabolic 
disturbances that are a consequence of excessive renal calcium loss or excessive fatty tissue 
content (Okurowska-Zawada et al., 2009). 
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Children with cerebral palsy (CP) are growing slowly. The impact of this altered growth on 
skeletal development and bone density is a difference in linear growth which becomes more 
accentuated over time compared with their typically growing peers. In addition, as growth 
slows, the bone mineral density also falls further outside the normal range (Houlihan et al., 
2009). Significantly decreased bone density is virtually universal in non-ambulatory children 
with moderate to severe CP after the age of 10 years (Henderson et al., 2002); Bone-mineral 
content and density were measured in a study by dual energy X-ray absorptiometry in the 
proximal femur, femoral neck, and total body of nutritionally adequate children (n=17; 11 
girls, six boys; aged 7.6 to 13.8 years) with spastic cerebral palsy (CP) and found that non-
independent ambulators had lower z scores for total body BMD, femoral neck BMD, and 
BMC than independent ambulators (Chad et al., 2000). The potential causes of deficient bone 
mineralization in this population are multiple, including poor nutrition and abnormal 
vitamin D metabolism. Findings from recent studies (Shaw et al. 1994, Henderson et al. 1995, 
Wilmhurst et al. 1996) suggest that non-nutritional factors, such as ambulation, may 
contribute to the alterations in body composition observed in children with CP. 
5.1 Interventions to prevent bone loss 
5.1.1 Weight bearing activities-cycling-body weight supported treadmill 
The effect of standing in bone after SCI has been investigated by many researchers. A 
beneficial effect on bone mass using passive mechanical loading has been shown on 
preservation of bone mass in the region of the femoral shaft, but not at the proximal hip of 
standing and non-standing patients and relatively better-preserved densities in patients 
standing with braces than in those using a standing frame or standing wheelchair 
(Goemaere et al., 1994). A slower rate of bone loss in paraplegic subjects who did standing 
was expressed in a prospective study of 19 patients in acute SCI phase participated in early 
standing training program showed benefits concerning the reduction of cancellous bone loss 
compared to immobilized subjects (de Bruin and others 1999; Frey-Rindova and others 
2000), while no correlation for passive standing-training to bone status was found in another 
p QCT study (Eser et al., 2005).  Protection afforded by standing in the femoral diaphysis 
stands in contrast with the loss of bone in the proximal femur. This suggests that the 
transmission of forces through trabecular and cortical bone varies; so the less effective strain 
for the initiation of bone remodeling reaches faster cortical bone (Frost, 1992, 2001, 2003). 
Others also supported the concept of different strain thresholds bone remodeling control 
(Gutin & Kasper, 1992; LeBlanc et al., 2007; Smith et al., 2009). There is level 2 evidence 
(from 1 non-randomized prospective controlled trial) that Functional Electrical Stimulation 
(FES) - cycling did not improve or maintain bone at the tibial midshaft in the acute phase 
(Eser et al., 2003). Moreover, there is level 4 evidence (from 1 pre-post study) that 6 months 
of FES cycle ergometry increased regional lower extremity BMD over areas stimulated 
(Chen et al., 2005). Body weight supported treadmill training (BWSTT) did not alter the 
expected pattern of change in bone biochemical markers over time and bone density at 
fracture-prone sites (Giangregorio et al., 2009). 
5.1.2 Whole body vibration 
At a meeting of the American Society for Bone and Mineral Research results of a small 
randomised, placebo-controlled study among 20 children with cerebral palsy who used a 
similar, commercially available vibrating platform for 10 min per day, 5 days per week for 6 
months were reported (Ward et al., 2001). A significant increase in tibial, but not lumbar-
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spine bone density in the treated group was found despite the simplicity, short duration of 
the “vibration”, the young age of the children and the poor compliance (Eisman, 2001). 
 
 
Fig. 3. Weight bearing in disabled subjects; using standing frames, functional walking with 
orthoses between bars and crutches, even push-ups in the wheelchair (in case of multiple 
sclerosis with a clinical equivalent like tetraplegia) bone can be loaded and bone loss rate 
would be slower (unpublished photos of Dionyssiotis Y).   
After 6 months of whole body vibration (WBV) therapy in twenty children with cerebral palsy 
(age 6.2 to 12.3 years; 6 girls) randomized to either continue their school physiotherapy 
program unchanged or to receive 9 minutes of side-alternating WBV (Vibraflex Home Edition 
II®, Orthometrix Inc) not effect on areal BMD at the lumbar spine was observed, while areal 
BMD seemed to decrease somewhat in the cortical region of the femoral diaphysis. Authors 
explained that mechanical stimulation increases intracortical bone remodeling and thereby 
cortical porosity; moreover changes occurred in ways that are not reflected by areal BMD, but 
might be detectable by more sophisticated techniques such as such as peripheral quantitative 
computed tomography (Ruck et al., 2010). Low-intensity vibration (LIV) has shown to be 
associated with improvement in bone mineral density in post-menopausal women and 
children with cerebral palsy. Seven non-ambulatory subjects with SCI and ten able-bodied 
controls underwent transmission of a plantar-based LIV signal (0.27 +/- 0.11 g; 34 Hz) from 
the feet through the axial skeleton as a function of tilt-table angle (15, 30, and 45 degrees). SCI 
subjects and controls demonstrated equivalent transmission of LIV, with greater signal 
transmission observed at steeper angles of tilt which supports the possibility of the utility of 
LIV as a means to deliver mechanical signals in a form of therapeutic intervention to 
prevent/reverse skeletal fragility in the SCI population (Asselin et al., 2011). 
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Fig. 4. The Galileo Delta A TiltTable offers a wide variety of applications from relaxation to 
muscle training for a diverse range of patients who are unable to stand without support. The 
motor driven adjustable tilt angle of the Galileo Delta TiltTable (90°) allows vibration 
training with reduced body weight from 0 to 100%. This is ideal for deconditioned and 
disabled patients for gradually increasing training weights up to full body weight. System 
for application in adults (max. body height: 1.90 m) and children (max. body height: 1.50 
m).The Galileo Delta A TiltTable is exclusively available from the manufacturer Novotec 
Medical GmbH., (with permission). 
5.1.3 Drugs 
Calcitonin in varying doses and methods of administration has given variable results in 
paraplegia (preferred dosage regimen, treatment duration, and administration route for 
adequate efficacy in SCI patients’ remains unclear) (Chantraine et al., 1979a; Minaire, 1987). 
Likewise, the outcome using bisphosphonates has been variable. Etidronate produced long-
term benefit in lower limb bone mineral density (BMD) in selected walking SCI patients 
(Roux et al., 1998); whereas tiludronate appeared effective in reducing bone resorption and 
preserving bone mass in a histomorphometric study in 20 paraplegic patients (Chappard et 
al., 1995). Intravenous pamidronate has been shown to attenuate bone loss in SCI and 
normalize serum calcium in immobilization hypercalcemia (Bauman et al., 2005). 
Alendronate (1000 times more potent than etidronate), in an open observational study, 
reversed BMD loss in men with established SCI increased both axial and trabecular bone 
density and has proven efficacy and safety in men treated for osteoporosis, prevents 
hypercalciuria and bone loss after bed rest and lower leg fracture (Moran de Brito et al., 
2005; Zehnder et al., 2004). Six months after using zolendronic acid in the treatment group 
BMD showed differences in the response to treatment between the mixed trabecular/ 
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cortical regions (narrow neck and intertrochanteric) and the purely cortical shaft. With 
respect to cross-sectional geometry, bone cross-sectional area and sectional modulus (indices 
of resistance to axial and bending loads, where higher values would indicate a positive 
effect of treatment) increased at the hip and buckling ratio (an index of the instability of 
thin-walled cross sections, where lower values would suggest that the treatment is 
improving stability) decreased consistent with improved bone outcomes; at 12 months, 
narrow-neck femur values declined and intertrochanteric and femoral shaft BMD was 
maintained vs. placebo group which showed a decrease in bone outcomes and an increase in 
buckling ratio at the hip at 6 and 12 months, while with respect to bone prevention 4 mg i.v. 
were effective and well-tolerated to prevent BMD loss at the total hip and trochanter for up 
to 12 months following SCI (Bubbear et al; Shapiro et al., 2007). 
 
Clinical examination and management of bone loss in SCI
 history of the patient (co morbidities, 
neurologic complications, use of drugs 
which impair bone metabolism, alcohol, 
smoking and information about the level 
of injury, duration of paralysis, 
immobilization period, onset of 
rehabilitation, use of assistive devices and 
orthoses). 
 pharmacological treatment with 
bisphosphonates p.os and i.v. that have 
been studied in patients with spinal cord 
injuries and had positive effects on bone 
parameters. 
 Use of calcium supplements (monitoring 
renal function) and vitamin D. 
 anthropometric parameters (age, weight, 
body mass index, BMI) 
 clinical examination (level of injury 
according to American Spinal Injury 
Association Impairment Scale, AIS) and 
assessment of spasticity) 
 Education on falls prevention 
 Counseling regarding osteoporosis and 
related factors and identification of 
fractures in regions of impaired sensation. 
 imaging (bone densitometry by DXA at 
the hip and spine, and if possible,  p QCT 
at the the tibia or femur) 
 physical therapy including: a) range of 
motion exercises, b) loading of the skeleton 
to reduce bone loss, d) therapeutic 
standing-walking with orthoses, e) 
passive-active cycling 
 measurement of bone turnover indices in 
the serum (parathyroid hormone, alkaline 
phosphatase, calcium, vitamin D, PINP 
molecule, osteocalcin) and urinary 
excretion of 24 hour (calcium, 
hydroxyproline, aminoterminal (NTx) and 
carboxylterminal (CTx) intermolecular 
cross-linking domain of bone type-1 
collagen), which provide a good indicator 
of bone resorption.
 dietary interventions to improve dietary 
intake of calcium and nutrition indices. 
 
Table 1. An algorithm for the screening and management of osteoporosis in subjects with 
spinal cord injury (should be read top to bottom starting with the left column); adapted 
from: Dionyssiotis Y. (2009). Bone loss in paraplegia: A diagnostic and therapeutic protocol. 
Osteoporos Int  Vol. 20 (Suppl 1):S23-S176 (with permission). 
www.intechopen.com
 
Neurological Osteoporosis in Disabilities 289 
6. References 
Apkon, S.D., Fenton, L., & Coll, J.R. (2009). Bone mineral density in children with 
myelomeningocele. Dev Med Child Neurol, Vol. 51, No. 1, pp. 63-67. 
Asselin, P., Spungen, A.M., Muir, J.W., Rubin, C.T., & Bauman, W.A. (2011). Transmission of 
low-intensity vibration through the axial skeleton of persons with spinal cord 
injury as a potential intervention for preservation of bone quantity and quality.J 
Spinal Cord Med, Vol.34, No. 1, pp. 52-59. 
Ausili, E., Focarelli, B., Tabacco, F., Fortunelli, G., Caradonna, P., Massimi, L., Sigismondi, 
M., Salvaggio, E., &   Rendeli, C. (2008). Bone mineral density and body 
composition in a myelomeningocele children population: effects of walking ability 
and sport activity. Eur Rev Med Pharmacol Sci, Vol. 12, No.6, pp. 349-354. 
Bauman, W.A., & Schwartz E. (1997). Calcium metabolism and osteoporosis in individuals 
with spinal cord injury. Top Spinal Cord Inj Rehabil, Vol. 2, pp. 84-96. 
Bauman, W.A., Spungen, A.M., Morrison, N., Zhang, R.L., & Schwartz, E. (2005). Effect of a 
vitamin D analog on leg bone mineral density in patients with chronic spinal cord 
injury. J Rehabil Res Dev, Vol. 42, No. 5, pp. 625-634. 
Bauman, W.A., Wecht, J.M., Kirshblum, S., Spungen, A.M., Morrison, N., Cirnigliaro, C, & 
Schwartz, E. (2005). Effect of pamidronate administration on bone in patients with 
acute spinal cord injury. J Rehabil Res Dev, Vol. 42, No. 3, pp. 305-313. 
Bauman, W.A., Schwartz, E., Song, I.S., Kirshblum, S., Cirnigliaro, C., Morrison, N. & 
Spungen, A.M. (2009). Dual-energy X-ray absorptiometry overestimates bone 
mineral density of the lumbar spine in persons with spinal cord injury. Spinal Cord, 
Vol. 47, No 8, pp. 628-633. 
Biering-Sorensen, F., Hansen, B., & Lee, B.S. (2009). Non-pharmacological treatment and 
prevention of bone loss after spinal cord injury: a systematic review. Spinal Cord, 
Vol. 47, No. 7, pp. 508-518. 
Biering-Sorensen, F., Bohr, H.H., & Schaadt, O.P. (1991). Longitudinal study of bone mineral 
content in the lumbar spine, the forearm and the lower extremities after spinal cord 
injury. Europ J Clin Invest, Vol.20, pp. 330-335. 
Biering-Sorensen, F., Bohr, H.H., & Schaadt, O.P. (1988). Bone mineral content of the lumbar 
spine and lower extremities years after spinal cord lesions. Paraplegia, Vol. 26, pp. 
293- 301. 
Bikle, D.D., Halloran, B.P., & Morey-Holton, E. (1997). Spaceflight and the skeleton: lessons 
for the earthbound. Gravi Space Biol Bull, Vol. 10, No. 2, pp. 119-135. 
Bubbear, J.S., Gall, A., Middleton, F.R., Ferguson-Pell, M., Swaminathan, R., & Keen, R.W. 
(2011). Early treatment with zoledronic acid prevents bone loss at the hip following 
acute spinal cord injury. Osteoporos Int, Vol. 22, No. 1. pp. 271-279. 
Cavanagh, P.R., Licata, A.A., & Rice, A.J. (2005). Exercise and pharmacological 
countermeasures for bone loss during long-duration space flight. Gravit Space Biol 
Bull, Vol. 18, No. 2, pp. 39-58. 
Chad, K.E., McKay, H.A., Zello, G.A, Bailey, D.A., Faulkner, R.A., Snyder, R.E. (2000). Body 
composition in nutritionally adequate ambulatory and non-ambulatory children 
with cerebral palsy and a healthy reference group. Dev Med Child Neurol, Vol. 42, 
No. 5, pp. 334-339. 
Chantraine, A. (1978). Actual concept of osteoporosis in paraplegia. Paraplegia, Vol. 16, No 1, 
pp. 51-58. 
www.intechopen.com
 
Osteoporosis 290 
Chantraine, A., Heynen, G., & Franchimont, P. (1979). Bone metabolism, parathyroid 
hormone, and calcitonin in paraplegia. Calcif Tissue Int, Vol. 27, No. 3, pp. 199-204. 
Chantraine, A., van Ouwenaller, C., Hachen, H.J., Schinas, P. (1979). Intra-medullary 
pressure and intra-osseous phlebography in paraplegia. Paraplegia, Vol. 17, No. 4, 
pp. 391-399. 
Chantraine, A., Nusgens, B., & Lapiere, C.M. (1986). Bone remodeling during the 
development of osteoporosis in paraplegia. Calcif Tissue Int, Vol. 38, No. 6, pp. 323-
327. 
Chen, S.C., Lai, C.H., Chan, W.P., Huang, M.H., Tsai, H.W., & Chen, J.J. (2005). Increases in 
bone mineral density after functional electrical stimulation cycling exercises in 
spinal cord injured patients. Disabil Rehabil, Vol. 27, No. 22, pp. 1337-1341. 
Cosman, F., Nieves, J., Komar, L., Ferrer, G., Herbert, J., Formica, C., Shen, V., & Lindsay, R. 
(1998). Fracture history and bone loss in patients with MS. Neurology, Vol. 51, No. 4, 
pp. 1161-1165. 
Coupaud, S., McLean, A.N., & Allan, D.B. (2009). Role of peripheral quantitative computed 
tomography in identifying disuse osteoporosis in paraplegia. Skeletal Radiol, Vol. 38, 
No. 10, pp. 989-995. 
Clasey, J.L., Janowiak, A.L., & Gater, D.R. (2004). Relationship between regional bone 
density measurements and the time since injury in adults with spinal cord injuries. 
Arch Phys Med Rehabil, Vol. 85, pp. 59-64. 
Dauty, M., Perrouin-Verbe, B., Maugars, Y., Dubois, C., & Mathe, J.F. (2000). Supralesional 
and sublesional bone mineral density in spinal cord-injured patients. Bone, Vol. 27, 
No. 2, pp. 305-309. 
de Bruin, E.D., Frey-Rindova, P., Herzog, R.E., Dietz, V., Dambacher, M.A.,&  Stussi, E. 
(1999). Changes of tibia bone properties after spinal cord injury: effects of early 
intervention. Arch Phys Med Rehabil, Vol. 80, No. 2, pp. 214-220. 
Demirel, G., Yilmaz, H., Paker, N, & Onel S. (1998). Osteoporosis after spinal cord injury. 
Spinal Cord, Vol. 36, No. 12. pp. 822-825. 
Dionyssiotis, Y, Trovas, G., Galanos, A., Raptou, P., Papaioannou, N., Papagelopoulos, P., 
Petropoulou, K., & Lyritis, G.P. (2007). Bone loss and mechanical properties of tibia 
in spinal cord injured men. J Musculoskelet Neuronal Interact Vol.7, No. 1, pp. 62-68. 
Dionyssiotis,  Y., Petropoulou, K., Rapidi, C.A., Papagelopoulos, P., Papaioannou, N., 
Galanos, A., Papadaki, P., & Lyritis, G.P. (2008). Body composition in paraplegic 
men. J Clin Densitom, Vol.11, No.3, pp. 437-443. 
Dionyssiotis, Y., Lyritis, G.P., Papaioannou, N., Papagelopoulos, P., & Thomaides, T. (2009). 
Influence of neurological level of injury in bones, muscles, and fat in paraplegia. J 
Rehabil Res Dev, Vol. 46, No 8, pp. 1037-1044. 
Dionyssiotis, Y. (2009). Bone loss in paraplegia: A diagnostic and therapeutic protocol. 
Osteoporos Int, Vol. 20,  (Suppl 1):S23-S176. 
Dionyssiotis, Y., Lyritis, G.P., Mavrogenis, A.F., & Papagelopoulos, P.J. (2011a). Factors 
influencing bone loss in paraplegia. Hippokratia, Vol.15, No. 1, pp. 54-59. 
Dionyssiotis, Y. (2011b). Bone loss and fractures in multiple sclerosis: focus on 
epidemiologic and physiopathological features. Int J Gen Med, Vol. 4, pp. 505-509. 
Dionyssiotis, Y. (2011c). Spinal cord injury-related bone impairment and fractures: An 
update on epidemiology and physiopathological mechanisms. J Musculoskelet 
Neuronal Interact, Vol.11, No. 3, pp. 257-265 
www.intechopen.com
 
Neurological Osteoporosis in Disabilities 291 
Dionyssiotis Y. (2011d). Bone Loss in Spinal Cord Injury and Multiple Sclerosis. In: JH Stone, 
M Blouin, editors. International Encyclopedia of Rehabilitation. Available online: 
http://cirrie.buffalo.edu/encyclopedia/en/article/340/ 
Doty, S.B., & DiCarlo, E.F. (1995). Pathophysiology of immobilization osteoporosis. Curr 
Opin Orthop, Vol.6, No. 5, pp. 45-49. 
Dovio, A., Perazzolo, L., Osella, G., Ventura, M., Termine, A., Milano, E., Bertolotto, A., & 
Angeli, A. (2004). Immediate fall of bone formation and transient increase of bone 
resorption in the course of high-dose, short-term glucocorticoid therapy in young 
patients with multiple sclerosis. J Clin Endocrinol Metab, Vol. 89, No. 10, pp. 4923-
4928. 
Dudley-Javoroski, S., & Shields, R.K. (2008). Dose estimation and surveillance of mechanical 
loading interventions for bone loss after spinal cord injury. Phys Ther, Vol. 88, No 3, 
pp. 387-396. 
Dudley-Javoroski, S., & Shields, R.K. (2008). Muscle and bone plasticity after spinal cord 
injury: review of adaptations to disuse and to electrical muscle stimulation. J 
Rehabil Res Dev, Vol. 45, No. 2, pp. 283-296. 
Dudley-Javoroski, S., & Shields, R.K. (2010). Longitudinal changes in femur bone mineral 
density after spinal cord injury: effects of slice placement and peel method. 
Osteoporos Int, Vol. 21, No. 6, pp. 985-995. 
Eisman, J.A. (2001). Good, good, good... good vibrations: the best option for better bones? 
Lancet, Vol. 358, No. 9297, pp. 1924-1925. 
Eser, P., de Bruin, E.D., Telley, I., Lechner, H.E., Knecht, H., & Stussi, E. (2003). Effect of 
electrical stimulation-induced cycling on bone mineral density in spinal cord-
injured patients. Eur J Clin Invest, Vol. 33, No 5, pp. 412-419. 
Eser, P., Frotzler, A., Zehnder, Y., Wick, L., Knecht, H., Denoth, J, & Schiessl H. (2004). 
Relationship between the duration of paralysis and bone structure: a pQCT study 
of spinal cord injured individuals. Bone, Vol. 34, No. 5, pp. 869-880. 
Eser, P., Frotzler, A., Zehnder, Y., & Denoth, J. (2005). Fracture threshold in the femur and 
tibia of people with spinal cord injury as determined by peripheral quantitative 
computed tomography. Arch Phys Med Rehabil, Vol. 86, No. 3, pp. 498-504. 
Eser, P., Frotzler, A., Zehnder, Y., Schiessl, H., & Denoth, J. (2005). Assessment of 
anthropometric, systemic, and lifestyle factors influencing bone status in the legs of 
spinal cord injured individuals. Osteoporos Int, Vol. 16, No. 1, pp. 26-34. 
Fattal, C., Mariano-Goulart, D., Thomas, E., Rouays-Mabit, H., Verollet, C., & Maimoun, L. 
(2011). Osteoporosis in persons with spinal cord injury: the need for a targeted 
therapeutic education. Arch Phys Med Rehabil, Vol. 92, No. 1, pp. 59-67. 
Faulkner, M.A., Ryan-Haddad, A.M., Lenz, TL, & Degner, K. (2005). Osteoporosis in long-
term care residents with multiple sclerosis. Consult Pharm, Vol. 20, No. 2, pp. 128-
136. 
Frotzler, A., Coupaud, S., Perret, C., Kakebeeke, T.H., Hunt, K.J., Donaldson, Nde. N., & 
Eser, P. (2008). High-volume FES-cycling partially reverses bone loss in people with 
chronic spinal cord injury. Bone, Vol. 43, No. 1, pp. 169-176. 
Frotzler, A., Coupaud, S., Perret, C., Kakebeeke, T.H., Hunt, K.J., & Eser, P. (2009). Effect of 
detraining on bone and muscle tissue in subjects with chronic spinal cord injury 
after a period of electrically-stimulated cycling: a small cohort study. J Rehabil Med, 
Vol. 41, No. 4, pp. 282-285. 
www.intechopen.com
 
Osteoporosis 292 
Garland, D.E., Stewart, C.A., Adkins, R.H., Hu, S.S., Rosen, C., Liotta, F.J., & Weinstein, D.A. 
(1992). Osteoporosis after spinal cord injury. J Orthop Res, Vol. 10, No. 3, pp. 371-
378. 
Garland, D.E., Foulkes, G.D., Adkins, R.H., Stewart, C.A., & Yakura, J.S. (1994). Regional 
osteoporosis following incomplete spinal cord injury. Contemporary Orthopaedics, 
Vol. 28, pp. 134-139. 
Garland, D.E., Adkins, R.H., Matsuno, N.N., & Stewart, C.A. (1999). The effect of pulsed 
electromagnetic fields on osteoporosis at the knee in individuals with spinal cord 
injury. J Spinal Cord Med, Vol. 22, No 4, pp. 239-245. 
Garland, D.E., Adkins, R.H., Stewart, C.A., Ashford, R., & Vigil, D. (2001). Regional 
osteoporosis in women who have a complete spinal cord injury. J Bone Joint Surg 
Am, Vol. 83-A, No. 8, pp. 1195-200. 
Garland, D.E., Adkins, R.H., Kushwaha, V., & Stewart, C. (2004a). Risk factors for 
osteoporosis at the knee in the spinal cord injury population. J Spinal Cord Med, Vol. 
27, No. 3, pp. 202-206. 
Garland, D.E., Adkins, R.H., Scott, M., Singh, H., Massih, M., & Stewart, C. (2004b). Bone 
loss at the os calcis compared with bone loss at the knee in individuals with spinal 
cord injury. J Spinal Cord Med, Vol. 27, No. 3, pp. 207-211. 
Giangregorio, L.M., & Blimkie, C.J. (2002). Skeletal adaptations to alterations in weight-
bearing activity: a comparison of models of disuse osteoporosis. Sports Med, Vol. 32, 
No 7, pp. 459-476. 
Giangregorio, L.M., & Webber, C.E. (2004). Speed of sound in bone at the tibia: is it related 
to lower limb bone mineral density in spinal-cord-injured individuals? Spinal Cord, 
Vol. 42, No 3, pp. 141-145. 
Giangregorio, LM, Craven, B.C., & Webber, C.E. (2005). Musculoskeletal changes in 
women with spinal cord injury: a twin study. J Clin Densitom, Vol. 8, No. 3, pp. 
347-351. 
Giangregorio, L.M., Thabane, L., Debeer, J., Farrauto, L., McCartney, N., Adachi, J.D., & 
Papaioannou, A. (2009). Body weight-supported treadmill training for patients 
with hip fracture: a feasibility study. Arch Phys Med Rehabil, Vol. 90, No. 12, pp. 
2125-2130. 
Griffiths, H.J., Bushueff, B.,& Zimmerman, R.E. (1976). Investigation of the loss of bone 
mineral in patients with spinal cord injury. Paraplegia, Vol.14, No. 3, pp. 207-212. 
Gutin, B., & Kasper, M.J. (1992). Can vigorous exercise play a role in osteoporosis 
prevention? A review. Osteoporos Int, Vol. 2, No. 2, pp. 55-69. 
Hamdy, R.C., Krishnaswamy, G., Cancellaro, V., Whalen, K., & Harvill, L. (1993). Changes 
in bone mineral content and density after stroke. Am J Phys Med Rehabil, Vol. 72, pp. 
188–191. 
Henderson, R.C., Lin, P.P., & Greene, W.B. (1995). Bone-mineral density in children and 
adolescents who have spastic cerebral palsy. Journal of Bone and Joint Surgery, Vol. 
77A, pp. 1671–1681. 
Henderson, R.C., Lark, R.K., Gurka, M.J, Worley, G., Fung, E.B., Conaway, M., Stallings, 
V.A., & Stevenson, R.D. (2002).  Bone density and metabolism in children and 
adolescents with moderate to severe cerebral palsy. Pediatrics Vol. 110, No.1, 
p.5. 
www.intechopen.com
 
Neurological Osteoporosis in Disabilities 293 
Houlihan, C.M., & Stevenson RD. (2009). Bone density in cerebral palsy. Phys Med Rehabil 
Clin N Am, Vol. 20, No. 3, pp. 493-508. 
Jiang, S.D., Jiang, L.S., & Dai, L.Y. (2007). Changes in bone mass, bone structure, bone 
biomechanical properties, and bone metabolism after spinal cord injury: a 6-month 
longitudinal study in growing rats. Calcif Tissue Int, Vol. 80, No.3, pp. 167-175. 
Jiang, S.D., Jiang, L.S., & Dai, L.Y. (2007). Effects of spinal cord injury on osteoblastogenesis, 
osteoclastogenesis and gene expression profiling in osteoblasts in young rats. 
Osteoporos Int, Vol. 18, No 3, pp. 339-349. 
Jones, L.M., Legge, M., & Goulding, A. (2002). Intensive exercise may preserve bone mass of 
the upper limbs in spinal cord injured males but does not retard demineralisation 
of the lower body. Spinal Cord, Vol. 40, No. 5, pp. 230-235. 
Kannisto, M., Alaranta, H., Merikanto, J., Kroger, H., & Karkkainen, J. (1998). Bone 
mineral status after pediatric spinal cord injury. Spinal Cord, Vol. 36, No 9, pp. 
641-646. 
Karlsson, A.K., Friberg, P., Lonnroth, P., Sullivan, L., & Elam, M.  (1998). Regional 
sympathetic function in high spinal cord injury during mental stress and 
autonomic dysreflexia. Brain, Vol. 121, pp. 1711–1719. 
Kiratli, B.J., Smith, A.E., Nauenberg, T., Kallfelz, C.F., & Perkash, I. (2000). Bone mineral and 
geometric changes through the femur with immobilization due to spinal cord 
injury. J Rehabil Res Dev, Vol. 37, No. 2, pp. 225-233. 
Kondo, H., Nifuji, A., Takeda, S., Ezura, Y., Rittling, S.R., Denhardt, D.T., Nakashima, K., 
Karsenty, G., & Noda, M. (2005). Unloading induces osteoblastic cell suppression 
and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. 
J Biol Chem., Vol. 280, pp. 30192-30200.  
Kurban, S., Akpinar, Z., & Mehmetoglu, I. (2008). Receptor activator of nuclear factor kappa 
B ligand (RANKL) and osteoprotegerin levels in multiple sclerosis. Mult Scler, 
Vol.14, pp. 431-432. 
Lakatos, P., Nagy, Z., Kiss, L., Horvath, C., Takacs, I., Foldes, J., Speer, G., & Bossanyi, A. 
(2000). Prevention of corticosteroid-induced osteoporosis by alfacalcidol. Z 
Rheumatol, Vol. 59, Suppl 1, pp. 48-52. 
Lanyon, L.E., Rubin, C.T., & Baust, G. Modulation of bone loss during calcium insufficiency 
by controlled dynamic loading. (1986). Calcif Tissue Int, Vol. 38, pp. 209-216. 
Lazo, M.G., Shirazi, P., Sam, M., Giobbie-Hurder, A., Blacconiere, M.J., & Muppidi, M. 
(2001). Osteoporosis and risk of fracture in men with spinal cord injury. Spinal Cord, 
Vol. 39, No 4, pp. 208-214. 
LeBlanc, A.D., Evans, H.J., Engelbretson, D.A., & Krebs, J.M. (1990). Bone mineral loss and 
recovery after 17 weeks of bed rest. J Bone Miner Res, Vol. 5, pp. 843-850. 
LeBlanc, A.D., &  Schneider, V. (1992). Countermeasures against space flight related bone 
loss. Acta Astronaut, Vol. 27, pp. 89-92. 
LeBlanc, A.D., Spector, E.R., Evans, H.J., & Sibonga, J.D. (2007). Skeletal responses to space 
flight and the bed rest analog: a review. J Musculoskelet Neuronal Interact, Vol. 7, No. 
1, pp. 33-47. 
Leslie, W.D., & Nance, P.W. Dissociated hip and spine demineralization: a specific finding in 
spinal cord injury. Arch Phys Med Rehabil, Vol.74, pp. 960-964. 
Leeds, E.M., Klose, K.J., Ganz, W., Serafini, A., & Green, B.A. (1990). Bone mineral density 
after bicycle ergometry training. Arch Phys Med Rehabil Vol. 71, No. 3, pp. 207-209. 
www.intechopen.com
 
Osteoporosis 294 
Levasseur, R., Sabatier, J.P., Potrel-Burgot, C., Lecoq, B., Creveuil, C., & Marcelli, C. (2003). 
Sympathetic nervous system as transmitter of mechanical loading in bone. Joint 
Bone Spine, Vol. 70, pp. 515-519. 
Lofvenmark, I., Werhagen, L., & Norrbrink, C. (2009). Spasticity and bone density after a 
spinal cord injury. J Rehabil Med, Vol. 41, No 13, pp. 1080-1084. 
Maimoun, L., Couret, I., Micallef, J.P., Peruchon, E., Mariano-Goulart, D., Rossi, M., Leroux, 
J.L., & Ohanna, F. (2002). Use of bone biochemical markers with dual-energy x-ray 
absorptiometry for early determination of bone loss in persons with spinal cord 
injury. Metabolism, Vol. 51, No.8, pp. 958-963. 
Maimoun, L., Couret, I., Mariano-Goulart, D., Dupuy, A.M., Micallef, J.P., Peruchon, E., 
Ohanna, F., Cristol, J.P., Rossi, M., & Leroux, J.L. (2005). Changes in 
osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals 
markers in patients with recent spinal cord injury. Calcif Tissue Int, Vol. 76, No. 6, 
pp. 404-411. 
Maimoun, L., Fattal, C., Micallef, J.P., Peruchon, E, & Rabischong, P. (2006). Bone loss in 
spinal cord-injured patients: from physiopathology to therapy. Spinal Cord Vol. 44, 
No. 4, pp. 203-210. 
Marrie, R.A., Cutter, G., Tyry, T., & Vollmer, T. (2009). A cross-sectional study of bone 
health in multiple sclerosis. Neurology, Vol. 73, No 17, pp. 1394-1398. 
Modlesky, C.M., Bickel, C.S., Slade, J.M., Meyer, R.A., Cureton, K.J., & Dudley, G.A. (2004). 
Assessment of skeletal muscle mass in men with spinal cord injury using dual-
energy X-ray absorptiometry and magnetic resonance imaging. J Appl Physiol Vol. 
96, pp. 561-565. 
Moran de Brito, C.M., Battistella, L.R., Saito, E.T., & Sakamoto, H. (2005). Effect of 
alendronate on bone mineral density in spinal cord injury patients: a pilot study. 
Spinal Cord, Vol. 43, No. 6, pp. 341-348. 
Nieves, J., Cosman, F., Herbert, J., Shen, V., & Lindsay R. (1994). High prevalence of vitamin 
D deficiency and reduced bone mass in multiple sclerosis. Neurology, Vol. 44, No. 9, 
pp. 1687-1692. 
NIH. (2001). NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, 
and Therapy. JAMA. pp. 785-795. 
Okurowska-Zawada, B., Konstantynowicz, J., Kulak, W., Kaczmarski, M., Piotrowska-
Jastrzebska, J., Sienkiewicz, D., & Paszko-Patej, G. (2009). Assessment of risk factors 
for osteoporosis and fractures in children with meningomyelocele. Adv Med Sci, 
Vol. 54, No 2, pp. 247-252. 
Ozgocmen, S., Bulut, S., Ilhan, N., Gulkesen, A., Ardicoglu, O., & Ozkan, Y. (2005). Vitamin 
D deficiency and reduced bone mineral density in multiple sclerosis: effect of 
ambulatory status and functional capacity. J Bone Miner Metab, Vol. 23, No 4, 309-
313. 
Parfitt, A.M. (1981). Bone effects of space flight: analysis by quantum concept of bone 
remodelling. Acta Astronaut, Vol. 8, No. (9-10), pp. 1083-1090. 
Perez Castrillon, J.L., Cano-del Pozo, M., Sanz-Izquierdo, S., Velayos-Jimenez, J., & Dib-
Wobakin, W. (2003). Bone mineral density in patients with multiple sclerosis: the 
effects of interferon. Rev Neurol Vol. 36, No. 10, pp. 901-903. 
Phaner, V., Charmetant, C., Condemine, A., Fayolle-Minon, I., Lafage-Proust, M.H., & 
Calmels, P. Osteoporosis in spinal cord injury. Screening and treatment. Results of 
www.intechopen.com
 
Neurological Osteoporosis in Disabilities 295 
a survey of physical medicine and rehabilitation physician practices in France. 
Proposals for action to be taken towards the screening and the treatment. Ann Phys 
Rehabil Med, Vol. 53, No. 10, pp. 615-620. 
Pouilles, J.M., Ribot, C., Tremollieres, F., & Guell, A. (1992). Vertebral, femoral and radial 
bone density in simulation of prolonged weightlessness. Experience with healthy 
volunteers. Presse Med, Vol. 21, No 4, pp. 160-164. 
Quan, A., Adams, R., Ekmark, E., & Baum, M. (1998). Bone mineral density in children with 
myelomeningocele. Pediatrics, Vol. 102, No. 3, E34. 
Quan, A., Adams, R., Ekmark, E., & Baum, M. (2003). Bone mineral density in children with 
myelomeningocele: effect of hydrochlorothiazide. Pediatr Nephrol Vol. 18, No 9, pp. 
929-933. 
Ramnemark, A., Nyberg, L., Lorentzon, R., Englund, U., & Gustafson, Y. (1999).Progressive 
hemiosteoporosis on the paretic side and increased bone mineral density in the 
nonparetic arm the first year after severe stroke. Osteoporos Int, Vol. 9, No. 3, pp. 
269-275.  
Ramnemark, A., Nyberg, L., Lorentzon, R., Olsson, T., & Gustafson, Y. (1999). 
Hemiosteoporosis after severe stroke, independent of changes in body composition 
and weight. Stroke, Vol. 30, No. 4, pp. 755-760. 
Reiter, A.L., Volk, A., Vollmar, J., Fromm, B.,& Gerner, H.J. (2007). Changes of basic bone 
turnover parameters in short-term and long-term patients with spinal cord injury. 
Eur Spine J, Vol.16, No. 6, pp. 771-776. 
Roberts, D., Lee, W., Cuneo, R.C., Wittmann, J., Ward, G., Flatman, R., McWhinney, B., & 
Hickman, P.E. (1998). Longitudinal study of bone turnover after acute spinal cord 
injury. J Clin Endocrinol Metab, Vol. 83, No. 2, pp. 415-422. 
Runge, M., Rehfeld, G., & Schiessl, H. Skeletal adaptations in hemiplegic patients. (2004). J 
Musculoskelet Neuronal Interact, Vol. 4, No 2, pp. 191-196.  
Rubin, C., Xu, G., & Judex, S. (2001). The anabolic activity of bone tissue, suppressed by 
disuse, is normalized by brief exposure to extremely low-magnitude mechanical 
stimuli. Faseb J, Vol. 15, No 12, pp. 2225-2229. 
Ruck, J., Chabot, G., & Rauch, F. Vibration treatment in cerebral palsy: A randomized 
controlled pilot study. J Musculoskelet Neuronal Interact. Vol.10, No 1, pp. 77-83.  
Sabo, D., Blaich, S., Wenz, W., Hohmann, M., Loew, M., & Gerner, H.J. (2001). Osteoporosis 
in patients with paralysis after spinal cord injury. A cross sectional study in 46 male 
patients with dual-energy X-ray absorptiometry. Arch Orthop Trauma Surg, Vol.121, 
No. (1-2), pp. 75-78. 
Sato, Y., Maruoka, H., Oizumi, K., & Kikuyama, M. (1996). Vitamin D deficiency and 
osteopenia in the hemiplegic limbs of stroke patients. Stroke, Vol. 27, pp. 2183–
2187. 
Sato, Y., Maruoka, H., Honda, Y., Asoh, T., Fujimatsu, Y., & Oizumi, K. Development 
osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol, Vol. 36, pp. 
278-283. 
Sato, Y., Maruoka, H., & Oizumi, K. Amelioration of hemiplegia associated osteopenia more 
than 4 years after stroke by 1 alphahydroxyvitamin D3 and calcium 
supplementation. Stroke, Vol. 28, pp. 736–739. 
www.intechopen.com
 
Osteoporosis 296 
Sato, Y., Fuiimatsu, Y., Kikuvama, M., Kaii, M., & Oizumi, K. (1998). Influence of 
immobilization on bone mass and bone metabolism in hemiplegic elderly patients 
with a long-standing stroke. J Neural Sci, Vol. 156, pp. 205-210. 
Sato, Y., Kaji, M., & Oizomi, K. (1999). An alternative to vitamin D supplementation to 
prevent fractures in patients with MS. Neurology, Vol. 53, No. 2, pp. 437. 
Sato, Y.  (2000). Abnormal bone and calcium metabolism in patients after stroke. Arch Phys 
Med Rehabil, Vol. 81, pp. 117-121. 
Schwarzman, R.J. (2000). New treatments for reflex sympathetic dystrophy. N Engl J Med, 
Vol. 343, pp. 654–656. 
Shaw, N.J., White, C.P., Fraser, W.D., & Rosenbloom L. (1994) Osteopenia in cerebral palsy. 
Archives of Disease in Childhood, Vol. 71, pp. 235–238. 
Schwid, S.R., Goodman, A.D., Puzas, J.E., McDermott, M.P., & Mattson, D.H. (1996). 
Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 
Vol. 53, No. 8, pp. 753-757. 
Shields, R.K. (2002). Muscular, skeletal, and neural adaptations following spinal cord injury. 
J Orthop Sports Phys Ther, Vol. 32, No 2, pp. 65-74. 
Shojaei, H., Soroush, M.R., & Modirian, E. (2006). Spinal cord injury-induced osteoporosis in 
veterans. J Spinal Disord Tech, Vol. 19, No.2, pp. 114-117. 
Shuhaibar, M., McKenna, M.J., Au-Yeong, M., & Redmond, J.M. (2009). Favorable effect of 
immunomodulator therapy on bone mineral density in multiple sclerosis. Ir J Med 
Sci Vol. 178, No. 1, pp. 43-45. 
Sioka, C., Kyritsis, A.P., & Fotopoulos, A. (2009). Multiple sclerosis, osteoporosis, and 
vitamin D. J Neurol Sci, Vol. 287, No (1-2), pp. 1-6. 
Smeltzer, S.C., Zimmerman, V., & Capriotti, T. (2005). Osteoporosis risk and low bone 
mineral  density in women with physical disabilities. Arch Phys Med Rehabil, Vol. 
86, pp. 582-586. 
Smith, E.M., Comiskey, C.M., & Carroll, A.M. (2009). A study of bone mineral density in 
adults with disability. Arch Phys Med Rehabil, Vol. 90, No 7, pp. 1127-1135. 
Smith, S.M., Zwart, S.R., Heer, M.A., Baecker, N., Evans, H.J., Feiveson, A.H., Shackelford, 
L.C., & Leblanc, A.D. (2009). Effects of artificial gravity during bed rest on bone 
metabolism in humans. J Appl Physiol, Vol.107, No 1, pp. 47-53. 
Sniger, W., & Garshick, E. (2002). Alendronate increases bone density in chronic spinal cord 
injury: a case report. Arch Phys Med Rehabil, Vol. 83, No.1, pp. 139-140. 
Spector, E.R., Smith, S.M., & Sibonga, J.D. (2009). Skeletal effects of long-duration head-
down bed rest. Aviat Space Environ Med Vol. 80, No. (5 Suppl):A23-8. 
Stenager, E., Jensen, K. (1991). Fractures in multiple sclerosis. Acta Neurol Belg Vol. 91, No 5, 
pp. 296-302. 
Szollar, S.M., Martin, E.M., Sartoris, D.J., Parthemore, J.G., & Deftos, LJ. (1998). Bone mineral 
density and indexes of bone metabolism in spinal cord injury. Am J Phys Med 
Rehabil, Vol. 77, No. 1, pp. 28-35. 
Takamoto, S., Masuyama, T., Nakajima, M., Seikiya, K., Kosaka, H., Morimoto, S., Ogihara, 
T., & Onishi T. (1995). Alterations of bone mineral density of the femurs in 
hemiplegia. Calcif Tissue Int. Vol. 56, pp. 259 –262. 
Takata, S., & Yasui, N. (2001). Disuse osteoporosis. J Med Invest, Vol. 48, No. (3-4), pp. 147-
156. 
www.intechopen.com
 
Neurological Osteoporosis in Disabilities 297 
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K.L., Armstrong, D., Ducy. 
P., & Karsenty, G. (2002).  Leptin regulates bone formation via the sympathetic 
nervous system. Cell, Vol. 111, pp. 305-317.  
Teasell, R.W., Arnold, J.M., Krassioukov, A., & Delaney, G.A. (2000). Cardiovascular 
consequences of loss of supraspinal control of the sympathetic nervous system after 
spinal cord injury. Arch Phys Med Rehabil, Vol. 81, pp. 506-516.  
Tsuzuku, S., Ikegami, Y., & Yabe, K. Bone mineral density differences between paraplegic 
and quadriplegic patients: a cross-sectional study. Spinal Cord, Vol. 37, pp. 358-
361. 
Uebelhart, D., Demiaux-Domenech, B., Roth, M., & Chantraine, A. (1995). Bone metabolism 
in spinal cord injured individuals and in others who have prolonged 
immobilisation. A review. Paraplegia, Vol. 33, No 11, pp. 669-673. 
Ward, K.A., Alsop, C.W., Brown, S., Caulton, J., Adams, J.E., & Mughal Z. (2001). A 
randomized, placebo controlled, pilot trial of low magnitude, high frequency 
loading treatment of low bone mineral density in children with disabling 
conditions. J Bone Miner Res, Vol.16: S173. 
Wilmshurst, S., Ward, K., Adams, J.E., Langton, C.M., & Mughal, M.Z. (1996) Mobility status 
and bone density in cerebral palsy. Archives of Disease in Childhood, Vol. 75, pp. 164–
165. 
Weinstock-Guttman, B., Gallagher, E., Baier, M., Green, L., Feichter, J., Patrick, K., Miller, C., 
Wrest, K., & Ramanathan, M. (2004). Risk of bone loss in men with multiple 
sclerosis. Mult Scler, Vol. 10, No. 2, pp. 170-175. 
Whalen, R.T. A.S., & Grindeland, R.E. Proceedings of the NASA symposium on the 
influence of gravity and activity on muscle and bone; 1991. pp. 1-178. 
Whedon, G.D. (1984). Disuse osteoporosis: physiological aspects. Calcif Tissue Int, Vol.36, 
Suppl 1:S146-150. 
WHO. (1994). Assessment of fracture risk and its application to screening for 
postmenopausal osteoporosis. Report of a WHO Study Group. Geneva, pp. 1-129 . 
Wilmet, E., Ismail, A.A., Heilporn, A., Welraeds, D., & Bergmann, P. (1995). Longitudinal 
study of the bone mineral content and of soft tissue composition after spinal cord 
section. Paraplegia, Vol. 33, No 11, pp. 674-677. 
Wronski, T.J., & Morey, E.R. (1983). Alterations in calcium homeostasis and bone during 
actual and simulated space flight. Med Sci Sports Exerc, Vol.15, No. 5, pp. 410-414. 
Zehnder, Y., Risi, S., Michel, D., Knecht, H., Perrelet, R., Kraenzlin, M., Zach, G.A., & 
Lippuner, K. (2004). Prevention of bone loss in paraplegics over 2 years with 
alendronate. J Bone Miner Res, Vol. 19, No 7, pp. 1067-1074. 
Zehnder, Y., Lüthi, M., Michel, D., Knecht, H., Perrelet, R., Neto, I., Kraenzlin, M., Zäch, G., 
& Lippuner, K. (2004). Long-term changes in bone metabolism, bone mineral 
density, quantitative ultrasound parameters, and fracture incidence after spinal 
cord injury: a cross-sectional observational study in 100 paraplegic men. Osteoporos 
Int, Vol. 15, pp. 180-189. 
Zhang, H.,& Wu, J. (2010). A cross-sectional study of bone health in multiple sclerosis. 
Neurology Vol. 74, No. 19, pp. 1554; author reply 1555. 
Zhang, P., Hamamura, K., & Yokota, H. (2008). A brief review of bone adaptation to 
unloading. Genomics Proteomics Bioinformatics, Vol. 6, No.1, pp. 4-7. 
www.intechopen.com
 
Osteoporosis 298 
Zhao, W., Liu, Y., Cahill. C.M., Yang. W., Rogers. J.T. & Huang. X. (2009). The role of T cells 
in osteoporosis, an update. Int J Clin Exp Pathol, Vol.20, No.2, pp.544-552. 
Zorzon, M., Zivadinov, R., Locatelli, L., Giuntini, D., Toncic, M., Bosco, A., Nasuelli, D., 
Bratina, A., Tommasi, M.A., Rudick, R.A & Cazzato, G. (2005). Long-term effects of 
intravenous high dose methylprednisolone pulses on bone mineral density in 
patients with multiple sclerosis. Eur J Neurol, Vol. 12, No. 7, pp. 550-556. 
www.intechopen.com
Osteoporosis
Edited by PhD. Yannis Dionyssiotis
ISBN 978-953-51-0026-3
Hard cover, 864 pages
Publisher InTech
Published online 24, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Osteoporosis is a public health issue worldwide. During the last few years, progress has been made
concerning the knowledge of the pathophysiological mechanism of the disease. Sophisticated technologies
have added important information in bone mineral density measurements and, additionally, geometrical and
mechanical properties of bone. New bone indices have been developed from biochemical and hormonal
measurements in order to investigate bone metabolism. Although it is clear that drugs are an essential
element of the therapy, beyond medication there are other interventions in the management of the disease.
Prevention of osteoporosis starts in young ages and continues during aging in order to prevent fractures
associated with impaired quality of life, physical decline, mortality, and high cost for the health system. A
number of different specialties are holding the scientific knowledge in osteoporosis. For this reason, we have
collected papers from scientific departments all over the world for this book. The book includes up-to-date
information about basics of bones, epidemiological data, diagnosis and assessment of osteoporosis,
secondary osteoporosis, pediatric issues, prevention and treatment strategies, and research papers from
osteoporotic fields.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Yannis Dionyssiotis (2012). Neurological Osteoporosis in Disabilities, Osteoporosis, PhD. Yannis Dionyssiotis
(Ed.), ISBN: 978-953-51-0026-3, InTech, Available from:
http://www.intechopen.com/books/osteoporosis/neurological-osteoporosis-in-disabilities
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
